What are the FIRST-line pharmacologic classes typically used for chronic hypertension management?

• A. Beta blockers, ACE inhibitors, and calcium channel blockers
• B. Diuretics alone
• C. Thiazide diuretics, ACE inhibitors or ARBs, and calcium channel blockers
• D. Statins

Answer: (C)

The main concept here is which drug classes are typically started first when treating chronic hypertension. The best answer combines three foundational classes: thiazide diuretics, ACE inhibitors or ARBs, and calcium channel blockers.

Thiazide diuretics work by reducing blood volume and, over time, peripheral resistance, making them very effective across a broad patient population. They’re especially useful in older adults and are inexpensive, with solid evidence showing cardiovascular risk reduction when used as part of initial therapy.

ACE inhibitors and ARBs block the renin-angiotensin system, leading to vessel dilation and lower pressure. They’re particularly advantageous for patients with diabetes or chronic kidney disease due to kidney-protective effects and favorable metabolic profiles. However, they can cause cough (ACE inhibitors) or angioedema in some individuals, which is a consideration when choosing among them.

Calcium channel blockers prevent calcium from entering vascular smooth muscle, relaxing vessels and lowering BP. They are effective across diverse groups and are a good option when diuretics or RAAS inhibitors aren’t suitable or when additional BP reduction is needed. They’re especially useful in older patients and in some racial groups where thiazides or RAAS blockers are less effective as monotherapy.

Beta blockers and using a diuretic alone aren’t typically first-line for uncomplicated hypertension, and statins do not treat blood pressure. The trio above provides broad coverage with strong evidence for reducing blood pressure and cardiovascular risk in many patients, which is why they’re considered first-line.